SNCA and Parkinson disease: α-Synuclein may contribute to Parkinson’s disease pathology in a number of ways, and the presence of a specific form of α-synuclein, phosphorylated at serine 129 (pS129-α-synuclein), has been implicated in the pathogenesis of Parkinson’s disease [26,27,28].